Sign in

CIK 0001681682

  • Non-accelerated filer
  • Smaller reporting company

ENDRA Life Sciences Inc.

Sign in to watch
Ticker
NDRA
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
260579295
Phone
+1 734-335-0468
Business address
3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
Former names
Endra Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Chief Technology Officer bought 15,000 shares at $1.65 ($24,750)
  3. 4 Open-market buy Director bought 83,333 shares at $1.20 ($100,000)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Chief Technology Officer bought 1,500 shares at $3.40 ($5,100)
  12. 4 Open-market buy Director bought 10,000 shares at $0.17 ($1,700)
  13. 4 Open-market buy Chief Technology Officer bought 20,000 shares at $0.27 ($5,400)
  14. 4 Open-market buy Director bought 20,000 shares at $0.26 ($5,200)
  15. 4 Open-market buy Chief Technology Officer bought 25,000 shares at $0.21 ($5,250)
  16. 4 Open-market buy Chief Technology Officer bought 25,000 shares at $0.22 ($5,500)
  17. 4 Open-market buy Chief Executive Officer bought 5,100 shares at $0.19 ($969)
  18. 4 Open-market buy Director bought 100,000 shares at $0.20 ($19,630)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 9 · 174 filings